AP Gov Essay free essay sample

What is the responsible party model and what are its consequences for democracy? Political parties are very important fundamentals of United States Government. In a democracy, candidates should go through with what they promised they were going to do. However, this has proven to not always be the case. Critics of the American party system have proposed that a more responsible two-party system should be used to solve this problem.The responsible parry model calls for each party to present distinct, unimpressive programs; have the internal cohesion and discipline to carry out its program if elected; implement its programs if it is the majority party or state what it would do if it were in power; and accept responsibility for the performance of the government. Under this model, promises would be made easier to convert into actual government policy. Its consequence for a democracy would be that a partys officeholders would have firm control of the government, and they would be collectively (and not individually) expansible for their actions. We will write a custom essay sample on AP Gov Essay or any similar topic specifically for you Do Not WasteYour Time HIRE WRITER Only 13.90 / page This would cause many policies to be made that would contradict each other and the public would not have a direct say on the policies implemented. There would be a lot of confusion if all promises were kept because then the House and Senate would have little say when passing policies. Voters would know exactly who to blame for what government does and doesnt accomplish.

Toddler development assessments essays

Toddler development assessments essays Development assessment is a structured evaluation of all of the childs developmental skill such as physical, language, intellectual, social, and emotional skills. The development assessment of a toddler can provide very helpful information to parents. Assessment also holds great potential to help caregivers understand the children they care for. Development assessment can increase your knowledge about your child. The child pediatrician or teacher may supervise the child, and if they notice an area where the child is lagging, they may request and evaluation with a developmental assessment specialist. Also they may give you a suggestion on how to work with your child at home. It doesnt mean that the child has a problem; in many cases the result is that the child is absolutely normal and may not need further treatment. Since every child is different, the development assessment is different too. The development specialists will tailor the childs assessment according to his age. If the child pediatrician asks you for an evaluation you must be prepare to answer a wide variety of detailed questions about your child growth, movement, behavior, play, and interactions with family members an the rest of the world. This assessment is going to be conduct by a team that can include a pediatrician, audiologist, child psychologist, and child psychiatrist, among others. This teen will observe how the child plays, learns, reasons, moves, and interacts. The child will be expose to several tests. To get the best result for the child, both parents need to be prepare. Also they need to attend any meeting or screening exams. The child needs to be healthy and comfortable during testing. At the end parents must receive a written report of the assessment. If the results end with a delay, you can consider getting a second opinion. ...

In two paragraphs, compare and contrast rationalism and empiricism Essay

In two paragraphs, compare and contrast rationalism and empiricism - Essay Example Reason is the rationalist’s tool for determining the nature of knowledge about the objective world. The application of the tools, methods, and processes of logic, according to rationalists, should guide an individual to the kind of knowledge that conforms to the laws of logic. These usually begin from concepts that form in the mind. On the other hand, empiricism is the epistemological school of thought that argues that all knowledge comes from the senses. According to this school, all people are born with their minds representing a blank sheet of paper so that all subsequent experiences generate knowledge for the individual. Empiricism argues in favor of sense experience as the fundamental basis of all knowledge (Maritain 26). We acquire knowledge by interacting with the subjective world before we form ideas and knowledge about the shape of reality. In this manner, all knowledge becomes a posteriori. It must necessarily proceed from sense experience. Empiricists argue that all knowledge is based on precepts, which form after some form of experiences. These are then ordered in the mind before they are synthesized into workable

CJ3Book Review The body of the Condemned Essay Example | Topics and Well Written Essays - 1500 words

CJ3Book Review The body of the Condemned - Essay Example But they each define a certain penal style.† (Foucault, 1995, p. 7) Foucault points out that modern forms of punishment are, thankfully, not carried out in the same spirit or with the same purpose. Many legal reforms were instituted between the old world of executions and torture and the new world of prisons and labour camps, the main difference being that what used to be a public spectacle became, over time, a regimented process, more bureaucratic than anything else, that is carried out behind high walls and locked doors. For Foucault what is significant about this change is that the punishment is no longer something visibly displayed, and it no longer focuses so sharply on the human body of the convicted person. Foucault concedes that penalties such as imprisonment, forced labour, deportation and the like do also affect the human body but they do so indirectly: â€Å"The body now serves as an instrument or intermediary†¦physical pain, the pain of the body itself, is no longer the constituent element of the penalty.† (Foucault: 1995, p. 11) He observes that a whole army of â€Å"technicians† are now involved in the penal side of the criminal justice system, and one need only think of the modern prison to realise that he is right. Warders, chaplains, social workers, educators, even doctors and psychologists all participate in the process. In states and in periods where in states where the death penalty is or was permitted, there is also an increasing presence of technicians in the process. The methods chosen for death have veered away from elements of spectacle and torture and have become swifter, for example the guillotine in France, the hangman’s noose in England and the lethal injection in America. Technical experts accompany the convicted person right up to the moment of execution. Drugs are used to dull the sensations of inmates, and also to make sure that executions are free of physical pain. Foucault calls this a kind of d isconnection which makes the penalties non-corporeal and therefore distanced from the physical being of the person. Punishment in this way becomes, for Foucault something abstract, with only the most fleeting actual contact with the body of the victim. If modern punishment systems do not target the prisoner’s body any more, then the question of what exactly it does target then arises. Foucault suggests: â€Å"The expiation that once rained down upon the body must be replaced by a punishment that acts in depth on the heart, the thoughts, the will, the inclinations† (Foucault: 1995, p. 16) Some people might refer to this as the soul of the person, and cite moral or religious beliefs to underpin this view, but Foucault looks instead at the way attention has shifted away from the past crime that has been committed, and towards the person who has committed the crime and now deserves some kind of punishment. There is in modern criminal justice systems a belief that punishmen t can be used to change a person’s behaviour for the better, and perhaps even influence his nature and personality in a positive way. This can be done in a way that suppresses part of the person’s personality. Foucault also observes a modern fascination in the causes of crime, by which he means all the circumstances which surround it, including the background of the criminal and all the various factors which contributed to his committing the crime. This is a very important point, because it brings Foucault to make a serious judgement about modern

Consumer Behaviour Essay Example | Topics and Well Written Essays - 1750 words

Consumer Behaviour - Essay Example While the youth and children are the primary decision makers on certain categories of products, among the adults the decision rests with the one who contributes the maximum towards household expenses. Based on these factors Starbucks is advised to cater to the discerning consumers products and service that would make them feel distinguished. Table of Contents 1. Introduction 1 2. Motivation & Benefit 2.1 Theory of Planned Behavior 1 2.2 Self-identity 1 2.3 Uniqueness Theory 2 2.4 Scarcity and attractiveness 3 2.5 Organic coffee and its impact 3 2.5 Customer preferences 4 2.6 Physical environment 4 2.7 Recommendations for Starbucks 5 3. Family Life Cycle and Family Decision-Making 5 3.1 Family Life Cycle 5 3.2 Stages in FLC and choices 7 3.3 Family decision-making 8 References 10 1. Introduction Starbucks is an upscale, recognized coffee brand enjoying competitive advantage. They have 17,000 stores in 49 countries and their greatest strength is their strong brand image and a considera ble market share. The UK coffee market, according to a study by Mintel in 2010, is expected to grow and is forecast to be worth GBP976 Million by 2015 (PR Newswire, 2010). On an average adults consume about two cups of coffee per day and Starbucks has less than 1% of the global market share (Kotha & Glassman 2003). Competition being intense, Starbucks needs to understand the motivation and benefits that consumers seek. 2. Motivation & Benefit 2.1 Theory of Planned Behavior Consumer behavior is associated with idealized people and communicates information about consumers (Smith, Terry, Manstead, Louis, Kotterman & Wolfs, 2008). It communicates their personal values and their self-identity. The Theory of Planned Behavior (TPB) suggests that behavioral decisions are not spontaneous but the result of a reasoned process in which behavior is influenced, even if indirectly, by attitudes, norms and perceptions of control over the behavior (Smith et al. 2008). The attitudes, norms and the pe rception of control over behavior influence behavior through their impact on behavioral intention. Food choices including the intention of consuming environmentally friendly products are all influenced by the TPB. 2.2 Self-identity People buy a product for the value they can deliver. The purpose, the product and the person interact to shape consumer behavior and any changes on any of these could impact consumer behavior (Ratneshwar, Shocker, Cotte and Srivastava (1999). How the product or service contributes to their self-identity and well being influences consumer behavior. The teenagers, for instance, like to be seen at trendy places. To them the social experience and the perceived brand value hold importance (Lockyer 2009). Self-identity is the extent to which the individual sees him- or herself as a typical consumer of a product, and may play a role in the context of the consumer (Smith et al. 2008). Self-identity, an important determinant of behavior, reflects the label people use to describe themselves. To boost their self identity consumers can consume food and also consume food at places that would help distinguish them. Self-identity predicts intentions to consume fair trade products and unique products. 2.3 Uniqueness Theory Food can either be consumed publicly or privately. Consumers like to experience goods and services that will distinguish them from others. Hence advertising should be unique in its appeal to the coffee consumers.

Definition Of Generic Pharmaceutical Company Business Model Economics Essay

Definition Of Generic Pharmaceutical Company Business Model Economics Essay This is an essay to identify CIPLA a generic Pharmaceutical companys business model and to explain the reasons why the company has to change its existing business model. This is done by first identifying the term business model and then using the definition to explain the business model adopted by the company, also determining the inherent changes in world policies and economic environment that prompt the change of the present business model. The second part of the essay addresses the issue of the conflict between the big ethical pharmaceutical companies and the relatively smaller generic pharmaceutical companies business models. This is addressed by highlighting the big pharmaceutical companies business model and comparing the two models (which will reveal the nature of their competitive relationship) there by identifying if there seems to be a convergence in their models and they are both becoming competitors in the same market or companies producing the same products but competing in different markets or companies where a symbiotic relationship has become inevitable for their survival in this present economic situation. Conceptualization of a Business Model. A definition of a business model is required to highlight the context to which CIPLAs (a generic pharmaceutical company) business model can be identified. During my research I encountered various concepts of a business model such as the definition given by Chesbrough and Rosenbloom (2002) a coherent framework that takes technological characteristics and potentials as inputs, and converts them through customers and markets into economic outputs (p.532), comparatively, Rayport and Jaworski (2001 cited in Wimmer 2004) defined a business model as the four choices of (1) a value proposition or a value cluster for targeted customers (2) a market space offering which could be products, services, information or all three (3) a unique dependable resource system and (4) a financial model. However Shafer, Smith et al (2005) suggests that a representation of a firms underlying core logic and strategic choices for creating and capturing value (p.202); is a design or creation, not an accident; wha t structures are in place to ensure firms capture value. Factually no sole definition can adequately cover all aspects of the term business model; I will endeavour to use a combination of all the stated business model definitions to better recognize the Generic pharmaceutical companys business model. I focused on the definition of this model first as most generic companies including CIPLA initially followed this business model before the need for change in 2005. The focus on India is also due to the fact that CIPLA originated from there. Definition of Generic Pharmaceutical company business model. Generic pharmaceutical company business model in India is characterised by the production and selling of copy cat pharmaceutical drugs discovered and developed by the big ethical pharmaceutical companies such as GlaxoSmithKline (GSK), this was achieve through the reverse engineering of the drugs invented by the big ethical Pharmaceutical companies and sold at lower costs. This was made possible in India due to the availability of cheap labour in the country, the favourable environment encouraged by the Indian government at the time which allowed low restriction on process patent and little or no conformity with WTO regulations. This was confirmed by Greene (2007) who wrote that government policy culminated in various actions including: the abolition of product patents on food, chemicals, and drugs; the institution of process patents; the limitation of multinational equity share in India pharmaceutical companies, and the imposition of price controls on certain formulations and bulk dr ugs. He also highlighted that India has garnered a worldwide reputation for producing high quality, low cost generic drugs. Financial evaluation of CIPLAs business model Using the Profit and loss account for 2000-2010, sales turnover steady increases from 2000-2004 but in 2005 there is a decline of about 10% which can be attributed to the implementation of the WTO law that affected the number of drugs available for replication. This also affected the earnings per share which dropped from about 51 to about 13 in 2005. Investment and debt also showed a steep decline of over 100% from 2004-2005, this corresponds to the change in business environment which can infer a reduction of debt incurred for drug production. However the excise duty showed steady from 2000-2005 indicating company focus on domestic market but in 2006 there is a steady decline in excise duties paid and this can be as a result of increased exportation of drugs following a change in business model. Change in CIPLAs Business Model The era of this type of business model however draws to an end as various changes in the economic situation and world policy will threaten the very successful model in which the generics pharmaceutical companies in India have been thriving. In 2005 Indian government changed its law concerning patent drugs and fell in line with World Trade Organization (WTO) Trade Related Intellectual Property Agreement (TRIPs) this limited the production of certain drugs that was filed as a patent from January 1, 1995(Greene 2007). Another important point is that the rate at which ethical pharmaceutical companies are coming up with new blockbuster drugs is slowing down, with a shift from Research and development (RD) to marketing. This is as a result of the enormous cost to bring to the market a new drug ranging between 802million 1billion over a period of 10-15 years (Mogalian, Myrdal 2004). As inferred by Martinez and Goldstein (2007) statement that the century-old approach of finding chemicals to treat diseases is producing fewer and fewer drugs. Yusuf Hamied (CEO of CIPLA) stated that the World Trade Organization regulations, which since 2005 have prevented Indian generic drug firms from copying patented drugs, signifies that Indian generic companies have to change their business model or risk being swallowed up by multinational firms. (Livemint, 5th January 2010). Most generic companies in India adapted to this setback in their business model by transferring focus from domestic market in India and increase export of generic drugs to the United States and Western Europe, entering into RD agreements, mergers and acquisitions of foreign drug companies and developing alliances with foreign pharmaceutical firms. CIPLA however chose a slightly different approach than most pharmaceuticals by focusing on organic growth in India and only seldom indulging in strategic business alliances, technological services (such as knowhow transfer, plant supply etc) and in licensing with big pharmaceuticals. CIPLA also increased their export of generic drugs to the United States and Western Europe. Some points in CIPLAs corporate presentation in August 2009 highlight the companys focus: Business model based on international strategic alliances- Business focuses on organic growth and leads to reduced capital commitment and regulatory/litigation risks. RD targeted at ensuring efficient utilization of resources and focused at developing and launching niche products. The graph below shows a steady increase in the value of Indias pharmaceutical RD expenditure from 2001-2006 as a result of a shift in business model. Source: William Greene, US Trade Commission (2007) The emergence of Indias pharmaceutical industry and implications for the US generic drug market, US Office of Economics Working Paper 2007-05-A Business models of Big, Ethical pharmaceutical companies and the consequent reason for change of model. The big pharmaceutical company business model is the traditional pharmaceuticals company business model which comprises of large scale Research and Development departments which discover new drugs for diseases and the sale of those drugs to consumers .This is a rudimentary definition of their business model as it also entails many more components than those mentioned above for instance in recent times we see a shift of emphasis from the research and development to sales and marketing campaigns due to the competitive nature of the environment. A branded drug product is originally discovered and developed by a pharmaceutical company. In order for the company to market and sell their product they must first gain approval from the Food and Drug Administration (FDA) by submitting a New Drug Application. In this documentation the company submits data to establish a drugs clinical safety and efficacy. Other studies determine the characteristics of the drug dosage form, including the manufacturing process, drug stability, purity, strength, and how it dissolves. Once the drug receives FDA approval, the innovator company can then exclusively market and sell this brand-name product for as long as the company has patent protection. (Mogalian, Myrdal 2004) However a new external threat has evolved apart from the usual competition of rival companies in the form of Generics pharmaceutical companies. These companies as mentioned in prior section of the essay have used the process of reverse engineering to create cheaper replicas of the drugs produced by these big pharmaceutical companies and selling the drugs at cheaper costs to consumers. This has been of great profit to the generics companies as they had to indulge in little or no cost consuming research and development to come up with the drugs in the first place and the availability of low cost of production was just an added advantage to their business model. Martinez and Goldstein (2007) noted however that the rise of generics wouldnt matter so much if research labs were creating a stream of new hits. But that isnt happening. Though the industry doubled its investment from 2002 till 2006 in RD it yielded 43% less than it had in five years during the 1990s of chemical-based drugs. There is a change in the business environment for generic companies in India however with the 2005 adherence to WTO laws. They generics companies are focused on RD to produce their own patent drugs and generic drugs have become more accepted in Western countries over the years, with the rising costs of healthcare these governments are looking to cut costs and are therefore encouraging the adoption generic drug prescriptions to patients. Another major factor affecting the big pharmaceutical companies is the problem of expired patents. Companies like Pfizer that had a blockbuster drug called Lipitor a cholesterol lowering drug will be coming off patent in 2010 and this will allow the generics companies to bring in a cheaper replica of the drug which will reduce the sales of the company drastically. Patent expirations are a big problem. Drugs are granted 20 years of patent protection, Although companies often fail to get a product to market before half of that period has elapsed. Once it hits the market, however, the patent-protected drug is highly profitable: Typical gross margins are 90% to 95%. When patents expire, generic makers offer the products at a price much closer to the cost of production (Martinez and Goldstein 2007). *Sales data is from IMS World Review (except for China and Poland) ** Patented/generic split is from ESPICOM. Generic defined as a drug whose patent has expired ***2001 values for China; 2000 values for Poland; 2003 values for Brazil reflects patented/unpatented (unpatented includes branded unpatented, generics, similar) Sources: IMS; ESPICOM; Factiva; EGA; Mckinsey team Analysis This development will result in the increased encroachment on the market share of the big pharmaceutical companies, though we can see from the chart that countries like China, Brazil, India and Poland have higher percentage of generic drug usage than US, Japan, Germany, France and UK the problem of the global recession may cause an increase in the use of the generic drugs in these countries as well since developed countries like UK are hoping to cut costs on public expenditure like healthcare costs. Definition of relationships Based on these new developments in the business environment of pharmaceuticals companies and my research I begin to recognize a trend where big pharmaceuticals and generics have increasingly instances of working together in order to thrive in the new environment. This aids me in my definition of in tension asked in the question, I identify this as the type of relationship generating between the big pharmaceutical and the generics companies and we can see that it if morphing from a completely competitive one to a more competitive-collaborative relationship, where we can even see a convergence in their business models in some cases. We see big pharmaceutical companies are begin to return to India after the 2005 law passed by the government protecting their drugs, so they can benefit from the availability of cheap labor and low cost of innovative talent, they are even cooperating with the generics companies for Research and Development, in licensing and use of their distribution lines to transport their drugs to underdeveloped countries formally catered to by mainly generics companies. AstraZeneca, GlaxoSmithKline and Bristol-Myers Squibb have also recently suggested they will outsource at least some of their manufacturing. There are lots of people in India, China and Eastern Europe who can make products of the same quality as ours but at significantly less cost, says Bristol-Myers Squibb CEO James Cornelius (Martinez and Goldstein 2007). However though we see them working together big ethical pharmaceuticals companies still have some strategies to compete with generics pharmaceutical companies. Some defensive strategies of the big pharmaceutical companies are to develop new generic subsidiaries of their organization so as to be able to better compete with generics companies. By having their own licensed generic companies, they are able to limit the rate at which generics encroach on their market share for drugs that are off patents, they accomplish this by allowing their licensed patents to release generic copies of their blockbuster drugs into the market just before they are off patent thereby gaining market share before the other generic companies release theirs. In first nine months of this year, Novartiss generics unit, Sandoz, grew roughly three times as fast as its branded-drugs business and accounted for nearly 20% of overall revenue. The balance is changing, says Novartis CEO Dr. Vasella. In the coming quarte rs, we will continue to see a faster growth opportunity in generics. (Martinez and Goldstein 2007) Competitive strategies of the big pharmaceutical companies include investment in biotechnology and diversification. Biotechnology is of great appeal because of the inability for generics companies to create copies of the drugs as of now. Diversification on the other hand will allow the company to expand the range of services it offers its customers and allow it to get alternative sources of income. CONCLUSION In conclusion we make-out CIPLA business model to be the production of copycat drugs by reverse engineering of branded drugs and the sale of the generic drugs at cheaper prices to the India and any other country where the big pharmaceutical drugs do not have patent rights, however a change in the business model became inevitable in 2005 because of the Indian government adoption of WTO laws and caused a shift of the business model of CIPLA to focus more on RD for the production of its own Branded drugs and strategic alliances which entail cooperation with Big Ethical pharmaceutical companies through in-licensing and know how transfer. Another point to note is the change in relationship between the generic company and the big pharmaceutical where we see a competitive symbiotic relationship brewing, with increased dealings between the two types of firms where big pharmaceutical companies benefit from the cheaper cost of production and access to generic companies distribution pipelines a nd generics gain from the in licensing agreements where they share profits with the bug pharmaceutical companies. However big pharmaceutical companies still maintain development of competitive strategies to combat the generic companies by creation of their own generic companies and increased investment in both diversification and biotechnology. Biblography Rayport, J.F. , Jaworski, B.J.(2001). e-commerce, New York: McGraw Hill/Irwin. Wimmer M.A., Knowledge management in electronic governance. 5th ed. IFIP international. William Greene, The Emergence of Indias Pharmaceutical Industry and Implications for the U.S. Generic Drug Market (2007) CIPLA Corporate presentation August 2009 CIPLA Pharmaceuticals Yusuf Hamied: I Am Not Against Patents I Am Against Monopolies Published: May 07, 2009 in India [emailprotected] Pharmacist Erik Mogalian, Assistant professor Paul Myrdal of the University of Arizonas College Whats the difference between brand-name and generic prescription drugs? December 13, 2004Â   Big Pharma Faces Grim Prognosis Industry Fails to Find New Drugs to Replace Wonders Like Lipitor By BARBARA MARTINEZ and JACOB GOLDSTEIN December 6, 2007; Page A1

Internet Security Essay -- Internet Privacy Security Web Essays

Internet Security Internet Security is the most important aspect of information technology. It has been years since computer has been invented and to keep the information confidential we have to safeguard this information. The importance of integrating security measures into systems development. Every business has their own security systems to reach their goals of information security. The computer world created security systems in order to reduce risk, maintain confidentiality, ensure the reliability of data resources, and compliance with national security laws and privacy policies and laws. SECURITY STANDARDS There are several types of standards when integrating security measures into new systems. Some companies developed their own application that has their own standards; others usually follow well-established national or international standards especially if the systems they developed are to be used by government agencies or contractors. Two major standards developed by the United States government and the other by the International Standard Organization. The U.S. used of the information security standard not only for businesses but also for our homeland security. Ever since the September 11 incident we have developed a tighter security for every branch of the government. The new standard is being used most especially for our military from the Internet worldwide and others has to follow. The most important one is the issuance of immigration visas. Our land, air and water transportation has been the first one to put this into action and intelligence officer’s tract criminal ’s activities through these measures. These are the Standards from the Orange Book: Trusted Computer System Evaluation Criteria (TSE... ...rmation security but not people security. Sometimes people’s value diminished because of business. We are so lucky to have live in the United States of America knowing that our security is the first priority of our government. Through the use of information security our government was able to tract down some of the most dangerous people in the world who were also involved in the September 11 incident. We are the world’s leader in the military and democracy. To live in a secure world is to live in peace! Reference: Management Information Systems, Third Edition Effy Oz, http://www.jeis.co.jp/ http://www.alw.nih.gov/Security/security-www.html http://www.alw.nih.gov/Security/security-prog.html http://www.alw.nih.gov/Security/security-groups.html/ http://www.sans.org/resources/glossary.php http://www.firewallguide.com/newsletter.htm.